Craft
Vyriad

Vyriad

Total Funding

$24.4 M

Vyriad Summary

Company summary

Overview
Vyriad is a company that develops a biopharmaceutical platform designed to cure cancer. It offers oncolytic virus therapies, utilizing engineered viruses designed to target ovarian cancer, glioblastoma, mesothelioma, head and neck cancer, blood cancers, endometrial cancer, hematologic malignancies and, multiple myeloma and gastrointestinal cancer.
Type
Private
Status
Active
Founded
2016
HQ
Rochester, MN, US | view all locations
Website
http://www.vyriad.com/
Cybersecurity rating
Sectors

Key people

  • Stephen J. Russell

    Stephen J. Russell, President and Chief Executive Officer, Director

    • Edwin Kania, Chairman

      • Kah-Whye Peng

        Kah-Whye Peng, Chief Technical Officer

        • Nathan Stacy, Director

          LocationsView all

          1 location detected

          • Rochester, MN HQ

            United States

            2900 37th St NW building 110

          Footer menu